newsfilter
← Latest News
GlobeNewswire·

Nabriva Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

DUBLIN, Ireland and FORT WASHINGTON, Pa., Aug. 31, 2021 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ:NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infect